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30The use of pharmacologic MRI (phMRI) in mouse models of brain disorders allows noninvasive in vivo
assessment of drug-modulated local cerebral blood volume changes (ΔCBV) as one correlate of neuronal and
neurovascular activities. In this report, we employed CBV-weighted phMRI to compare cocaine-modulated
neuronal activity in dopamine transporter (DAT) knockout (KO) andwild-type mice. Cocaine acts to block the
dopamine, norepinephrine, and serotonin transporters (DAT, NET, and SERT) that clear their respective
neurotransmitters from the synapses, helping to terminate cognate neurotransmission. Cocaine consistently
reduced CBV, with a similar pattern of regional ΔCBV in brain structures involved in mediating reward in both
DAT genotypes. The largest effects (−20% to −30% ΔCBV) were seen in the nucleus accumbens and several
cortical regions. Decreasing response amplitudes to cocaine were noted in more posterior components of the
cortico-mesolimbic circuit. DAT KO mice had significantly attenuated ΔCBV amplitudes, shortened times to
peak response, and reduced response duration in most regions. This study demonstrates that DAT knockout
does not abolish the phMRI responses to cocaine, suggesting that adaptations to loss of DAT and/or retained
cocaine activity in other monoamine neurotransmitter systems underlie these responses in DAT KO mice.31
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Assessment of the effects of psychotropic substances requires an
understanding of their sites, mechanisms, and time courses of action.
Functional neuroimaging techniques have made it possible to study
drug-induced changes in brain activity in vivo (Leslie and James,
2000). Pharmacological magnetic resonance imaging (phMRI), a
variant of functional MRI, is well adapted to monitor drug action in
the brain dynamically and noninvasively and to map the brain
systems and networks targeted by psychoactive drugs (Chen et al.,
2001). A number of important classes of medications used in the
treatment of psychiatric disorders and many drugs of abuse target
plasma membrane reuptake transporters for the monoamine neuro-
transmitters dopamine, norepinephrine, and serotonin (DAT, NET,
and SERT, respectively) inhibiting the reuptake of the released
neurotransmitters (Gainetdinov and Caron, 2003).
Dopamine systems, including the cortico-mesolimbic system, are
crucial for normal reward-seeking behavior and are likely to make
major contributions to the development of addiction (Girault and
Greengard, 2004). Cocaine is a prototypical psychomotor stimulant
with powerful mood altering properties (Johanson and Fischman,76
77
781989; Uhl et al., 2002). It has dramatic effects on the reward pathway
through interaction with the monoamine transporters (Gainetdinov
and Caron, 2003). Moreover, chronic exposure has a multitude of
effects in the brain, including modulation of signaling cascades,
neurotrophic factors, monoamine receptors, and neuroplasticity (El-
Ghundi et al., 2007; Thomas et al., 2008). Contrary to initial
expectations, DAT knockout (KO) mice display evidence for cocaine
reinforcement in conditioned place preference and even in some self-
administration paradigms (Rocha et al., 1998; Sora et al., 1998).
However, in one line of DAT KOmice, individual mice differ somewhat
in their cocaine self-administration behavior. Most do not self-
administer. Those that do self-administer fail to continue responding
when challenged with more demanding schedules of reinforcement
(Thomsen et al., 2009). This may be due to disruption of aspects of
incentive motivation (or aversion) mediated by dopamine, since DAT
KO mice do not exhibit cocaine conditioned locomotion (Hall et al.,
2009). That cocaine is rewarding at all in DAT KOmice may be, in part,
a consequence of neuroadaptations in the SERT and NET systems,
consistent with the finding that SERT and NET blockers have
reinforcing effects in DAT KO mice that are not observed in wild-
type mice (Hall et al., 2002). These data suggest that although aspects
of cocaine reward are maintained, at least to a certain degree, in DAT
KO mice, the mechanisms underlying cocaine reward differ from
those in wild-type mice.I: Mapping the cerebral blood volume response to
roimage.2010.12.048
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2 T.-A. Perles-Barbacaru et al. / NeuroImage xxx (2010) xxx–xxxphMRI measures the hemodynamic responses to a pharmaco-
logical challenge and thus probes the activity of neuronal pathways
targeted by the drug based on the neurovascular consequences of
changed neuronal (and vascular) activities (Jenkins et al., 2004;
Mandeville et al., 1998; Schwarz et al., 2007a). This technique has
the potential for examining the underlying changes in regional
brain activity in mouse models of disorders that display links to
altered neurotransmitter activity, including attention deficit hyper-
activity disorder, narcolepsy, obesity, and drug addiction. However,
small brain size, rapid metabolic rates, susceptibility artifacts, and
the need for anesthesia render functional MRI challenging in mice.
Small animal imaging is carried out at high magnetic field strengths
(N7 T) to maximize signal intensity. In phMRI, the sensitivity to
functional changes is enhanced with exogenous magnetic resonance
contrast agents such as ultrasmall superparamagnetic iron oxide
particles (USPIO) that are retained in the blood pool and exhibit
long circulation times (Weissleder et al., 1990). The paramagnetic
signals generated by such superparamagnetic particles are so large
that most of the MRI signal is determined by the cerebral blood
volume (CBV), overwhelming blood oxygen level-dependent
(BOLD), and blood flow effects. Most current studies using this
technique have used rats (Mandeville et al., 2004, 1998; Schwarz et
al., 2007b) or nonhuman primates (Jenkins et al., 2004). A few
research teams have successfully performed CBV-weighted phMRI
in mice (Luo et al., 2008; Mueggler et al., 2003; Wu et al., 2004),
although low signal-to-noise ratio (SNR) and sensitivity have
precluded a broad range of investigations using genetically
engineered mouse models.
In the present report, we have examined, for the first time, effects
of DAT gene deletion on neurovascular responses to an acute cocaine
challenge. We have used a CBV-weighted phMRI technique in mice
and achieved good sensitivity to the CBV change with time
resolution of 1 min and spatial resolution of b0.2 mm. This
methodology has already proved useful in larger rodent and primate
systems (Chin et al., 2006; Jenkins et al., 2004; Mandeville et al.,
2005; Marota et al., 2000; Sanchez-Pernaute et al., 2007; Schwarz et
al., 2003). Adapting this approach for mouse brain imaging should
provide a valuable means for testing hypothesizes in a variety of
mouse model systems.
Materials and methods
CBV responses to cocaine were studied in 6 DAT KO mice and 6
wild-type control mice consisting of 4 wild-type littermates and 2
C57BL/6J female mice (The Jackson Laboratory, Bar Harbor, ME). The
DAT KO mice used in these experiments have been described
previously (Sora et al., 1998). Pilot experiments on isoflurane
anesthetized mice of different strains and ages were carried out to
establish a suitable cocaine dose. In bench top experiments that did
not involve MRI, the electrocardiogram, respiration, and expired CO2
(MicroCapStar CO2 Monitor, IITC Life Science Inc., CA) were
continuously recorded before and after cocaine injection. Criteria for
the choice of the cocaine dose were (a) no arousal from anesthesia
and (b) stable physiologic parameters after injection. Behavioral
changes have been reported starting at a cocaine dose of 5 mg/kg
intraperitoneal (IP) in conscious mice (Jamshidi et al., 2004), while
cocaine-induced seizures start to appear at a dose of 70 mg/kg IP.
Doses of 20 to 40 mg/kg IP increase striatal and nucleus accumbens
dopamine levels 3-fold in wild-typemice (Mateo et al., 2004; Rocha et
al., 1998). In this work, cocaine hydrochloride (Sigma-Aldrich, MO)
was dissolved in normal saline solution (5 mg/ml) for IP injection at a
dose of 30 mg/kg.
P904 (Guerbet Research, Aulnay-Sous-Bois, France) is a research
prototype USPIO with a hydrodynamic diameter of 25 to 30 nm
and a glucose derivative coating designed for macrophage and
vascular imaging applications (Sigovan et al., 2009). It wasPlease cite this article as: Perles-Barbacaru, T.-A., et al., Quantitative ph
cocaine in dopamine transporter knockout mice, NeuroImage (2010), dprovided as a 500 mM (≈28 mg/ml) solution and was diluted to
6 mg/ml in sterile normal saline solution for IV injection. A volume
of ≈4.2 μl/g body weight was injected IV resulting in a dose of
25 mg/kg.
All experiments were performed in accordance with protocols
approved by the Institutional Animal Care and Use Committee of the
California Institute of Technology.
In vivo phMRI
In vivo MRI experiments were performed in a horizontal bore
Bruker Biospec/Avance 7T/30 cm small animal MR system using a
custom made 12-rung linear birdcage RF coil (length 45 mm, inner
diameter 26 mm) for transmission and reception. The mice were
positioned prone in a plastic cradle with an integral head mask
providing 1.5 to 1.7% isoflurane in N2/O2 70%/30% and incorporated
ECG electrodes for the front paws and tail. Rectal temperature
(Opsens OTG-M, Canada) and respiration (BIOPAC Systems, CA)
were monitored continuously. Simultaneous recording of the elec-
trocardiogram during gradient echo imaging was not always reliable,
but heart rates at the start and end of acquisition were comparable.
Body temperature was maintained between 36 and 38 °C using
heated air passed through the RF coil and a cylindrical plastic
extension that covered the mouse body, preventing rapid loss of the
warm air. The isoflurane level was adjusted to achieve respiratory
rates of 80 to 120 breaths per minute and was not changed during
image acquisition. The mice were fitted with tail vein catheters for
USPIO injection and intraperitoneal catheters for drug injection. Both
catheters had extension lines with total volumes of 200 μl and were
preloaded with USPIO and drug in normal saline solution before
positioning the mouse in the magnet.
An autoshiming routine resulted in a 1H linewidth of b0.13 ppm
(FWHM) in a cube of 4×4×4 mm3 brain tissue. After obtaining stable
physiologic conditions, relative CBVmaps were obtained based on the
intravascular susceptibility effect of the USPIO (Berry et al., 1996;
Mandeville et al., 1998).
For each brain, 14 contiguous axial 0.75-mm-thick slices, with a
field of view of 19×19 mm2, were acquired from the olfactory bulb to
the cerebellum using a 2D multiple gradient echo sequence with
TR=600 ms, flip angle=35°, 100×100 matrix, spectral line width
60 kHz, three echoes at TE=2.5, 6.0 and 9.5 ms, and an acquisition
time of 1 min per repetition.
Fig. 1 illustrates the phMRI protocol: R2*-weighted images were
acquired for 30 min prior to contrast agent administration followed by
30 post-contrast baseline acquisitions. After the pharmacological
challenge, image acquisition continued for 90 min. The USPIO and
cocaine were injected by flushing the IV/IP catheter with 250 μl saline
solution over a duration of 1 min while the mouse was positioned
inside the scanner.
MRI data analysis
Pre-contrast and post-contrast images were automatically co-
registered with a 2D rigid body (3 parameters) model using
Automated Image Registration (AIR) software (Woods et al., 1998).
Image analysis was performed with ImageJ (Abramoff et al., 2004). No
spatial or temporal smoothing was applied to the data.
The relative signal decrease upon contrast agent administration is
1−SpostCA
.
SpreCA; ð1Þ
where SpreCA is the mean signal intensity prior to contrast agent (CA)
injection and SpostCA is the signal intensity averaged over the first five
acquisitions after contrast agent injection (Fig. 1). The signal decrease
depends on the relaxivity of the contrast agent and its initial tissuearmacologic MRI: Mapping the cerebral blood volume response to
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Fig. 1. Experimental protocol: in phMRI experiments gradient echo images were acquired continuously with a time resolution of 1 min. The baseline intervals before and after P904
injection were 30 min each. SpreCA. is the constant baseline signal before contrast agent injection; SpostCA is the average of five consecutive signals acquired immediately after contrast
agent injection, and S(t) is the time dependent CBV-weighted signal after contrast agent injection. The acquisitions in the interval between contrast agent and cocaine injection and
the acquisitions at N60 min after cocaine were used to detrend the signal and to derive the contrast agent washout rate.
3T.-A. Perles-Barbacaru et al. / NeuroImage xxx (2010) xxx–xxxconcentration. These factors determine the transverse relaxation
rate change
ΔR2 = −
1
TE
ln SpostCA
.
SpreCA
 
: ð2Þ
where TE is the echo time.
Prior to quantitative analysis, the signal intensity after contrast
agent injection, S(t), was detrended (Schwarz et al., 2003) to
eliminate the effect of contrast agent washout by fitting two time
intervals of S(t) prior to and N60 min after pharmacological challenge
(Fig. 1) to a two-parameter model (Perles-Barbacaru et al., 2010).
Assuming that the T2-weighted signal is a simple exponential function
(S0(t)∝exp[−TE R2*(t)]), we find that:
S0 tð Þ = SpreCAexp −TE⋅κ⋅exp
t
τ
  
ð3Þ
where SpreCA is defined as above. The fitting parameter κ provides an
estimate of the initial ΔR2* following USPIO injection (Eq. (2)), while
τ−1 is the apparent washout rate of the contrast agent from the tissue.
In this model, we assume negligible T1 effects, an instantaneous USPIO
bolus and mono-exponential USPIO washout in the plasma, since
USPIO is confined to the intravascular compartment.
The relative CBV change (ΔCBV) is calculated for each image voxel
according to Mandeville et al. (1998) by assuming a linear
relationship between CBV and ΔR2⁎:
ΔCBVðtÞ = ln S0 tð Þ=S tð Þ
 
ln SpreCA
.
S0 tð Þ
  ð4Þ
where S0(t) represents the fit to the signal time course after contrast
agent injection under resting conditions with no drug challenge
(Eq. (3)). S(t) refers to the measured signal after contrast agent
injection. We analyzed the ΔCBV using the signal from the 3rd echo at
TE=9.5 ms, while the ROIs were drawn on the images of the first two
echoes.
Quantitative analyses of the parametric maps from Eq. (4)
describing the CBV change upon cocaine injection were performed
by examining several cerebral ROIs forming the drug reward circuitry.
We analyzed ROIs in the prefrontal, frontal, and frontoparietal cortex
(CTX); nucleus accumbens (ACB); dorsal striatum (DS); amygdala
(AMY); hippocampal formation (HPF); thalamic nuclei (TH); hypo-
thalamus (HY); midbrain (MB); ventral tegmental area (VTA);
substantia nigra (SNr); pons (P); medulla (MY); and cerebellum
(CBX). To rule out confounding systemic vascular changes associated
with the pharmacological stimulus and independent of neuronal
activity, we also analyzed the signal change in an extra-cerebral ROI
located in the masseter or temporalis muscle.Please cite this article as: Perles-Barbacaru, T.-A., et al., Quantitative ph
cocaine in dopamine transporter knockout mice, NeuroImage (2010), dTo describe the regional time course of the ΔCBV response, we
used a simplified gamma variate model.
ΔCBV tð Þ = ΔCBVpeak
t
Tpeak
 !α
exp α 1− t
Tpeak
 ! !
ð5Þ
The three model parameters (ΔCBVpeak=amplitude, Tpeak=time
to peak, and α=shape factor) were compared between DAT KO and
wild-type control groups using unpaired T-tests. In particular, for each
ROI noted above, the gamma variate model (Eq. (5)) was fitted to the
data of one animal at a time and to the combined data from all animals
in one group (examples for ACB and VTA can be seen in Fig. 3). An F-
test was used to compare the relative difference in the sum of squares
of the residuals from each fit and the relative difference in the degrees
of freedom. To test for significant differences in each model
parameter, an F-test was applied to the results of nonlinear regression
with independent and shared parameter of interest. T-tests for each
model parameter confirmed the statistically significant differences
detected by the F-test. To test whether the entire response curves
were different, the F-test was performed on the results of the
nonlinear regression to the separate data and to the combined data of
both groups. Pb0.01 was considered statistically significant. Curve
fitting and statistical tests were performed using GraphPad Prism
version 4.03 for Windows (GraphPad Software, La Jolla, CA).
Results
During and within 1 min after intravenous injection of P904,
respiratory amplitudes and rates were increased. Pilot experiments
showed that cocaine doses up to 1.5 mg/kg IV or 30 mg/kg IP did not
alter these physiologic parameters for more than 3 min. We
administered cocaine intraperitoneally during MRI experiments to
avoid sudden hypervolemia and to avoid the tail and bodymotion that
often accompanied intravenous cocaine administration. An intraper-
itoneal dose of 30 mg/kg cocaine transiently reduced and then
increased the respiratory amplitude for 1 to 3 min.
Analysis of the signal from a ROI in the dorsal striatum (area 3.2±
0.2 mm2) acquired at TE=9.5 ms showed that a P904 dose of 25 mg/
kg yielded a relative signal decrease (Eq. (1)) of 0.58±0.02 during the
5 min following contrast agent injection with an apparent tissue half-
life (τ⋅ ln2) of 156±19 min (N=12, average ± standard error of the
mean). Although the apparent tissue half-life computed according to
Eq. (3) does not vary from region to region, it is greater than 2 h in all
regions. Thus, the detrending model in Eq. (3) takes reasonable
account of the slowly decreasing P904 concentration.
Saline injection produced no measurable effect on CBV (data not
shown). Fig. 2 shows that a spatially and temporally dependent CBV
change was observed in cerebral tissue of mice treated with cocaine,
while there was no measurable effect on extra-cerebral vasculature.
Cocaine induced a marked CBV decrease (Fig. 2) that lasted between
40 and 60 min. The ventral striatum/nucleus accumbens exhibited the
strongest response to cocaine.armacologic MRI: Mapping the cerebral blood volume response to
oi:10.1016/j.neuroimage.2010.12.048
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Fig. 2. Effect of IP cocaine on the signal time course in cerebral (nucleus accumbens,
open symbols) and in extra-cerebral tissue (muscle, closed symbols). Injection of
25 mg/kg P904 IV at t=−30 min (left arrow) yields a 62.5% signal drop in nucleus
accumbens (4.06 mm3) and 69.1% signal drop in muscle (9.58 mm3) at TE=9.5 ms. The
second arrow indicates the IP injection of cocaine (30 mg/kg), which leads to a signal
increase in the cerebral tissue corresponding to a CBV decrease. The error bars show the
standard deviation of the signal within the ROI in a single mouse. This is a typical signal
time course prior to detrending.
4 T.-A. Perles-Barbacaru et al. / NeuroImage xxx (2010) xxx–xxxThe time course of the ΔCBV response to cocaine in two ROIs
within the mesolimbic pathway is shown in Fig. 3 for DAT KO and
wild-type mice. The time courses in all examined ROIs, except
thalamic nuclei, differed significantly between DAT genotypes. Fig. 4
shows that the DAT KO mice display an attenuated ΔCBV response in
all regions except the hypothalamus, thalamus, pons, and medulla
oblongata. Also, in the knockout mice, peak responses were reached at
earlier time points for most brain structures and the total duration of
the hemodynamic response to cocaine was shorter than in wild-type
mice (Figs. 3 and 4).
Discussion
Drug-induced CBV changes
Species differences in cerebral responses to cocaine have been
reported previously (Lyons et al., 1996; Zocchi et al., 2001) but have343
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Fig. 3. ΔCBV response in two cerebral structures (nucleus accumbens and ventral
tegmental area) to an IP injection of 30 mg/kg cocaine at t=0. The error bars represent
SEM; N=6 DAT KO and N = 6 wild-type mice. The continuous black lines are the best
gamma variate fit with the 95% confidence interval shown as dashed gray lines.
Please cite this article as: Perles-Barbacaru, T.-A., et al., Quantitative ph
cocaine in dopamine transporter knockout mice, NeuroImage (2010), dremain unexplained. In this study, a negative ΔCBV response to
cocaine was observed in mice. In rats, ΔCBV increases after cocaine
challenge have been observed withMRI (Ceolin et al., 2007; Marota et
al., 2000; Schwarz et al., 2003, 2004), while cocaine-induced ΔCBV
decreases have been observed in humans (Kaufman et al., 1998).
Mechanisms for the negative CBV response may be related to reduced
cerebrovascular feedback and/or decreased neuronal activation
(Mandeville et al., 2005; Peoples et al., 1998) accompanied by a
decreased cerebral glucose metabolism (Lyons et al., 1996; Thanos et
al., 2008). Cerebral microvascular constriction has also been observed
in rhesus monkey brain slices upon micro-application of dopamine
(Krimer et al., 1998). Direct activation of D1 dopaminergic receptors
on arterioles results in vasodilation (Choi et al., 2006), although the
sign of the CBV response depends on both the effective concentration
of dopamine and the relative regional densities of receptors in the D1/
D5 and D2/D3 and possibly even D4 receptor families (Choi et al.,
2006). Cocaine-induced blockade of norepinephrine and serotonin
reuptake are also likely to influence the overall direction of
cardiovascular changes in both the wild type, perhaps especially in
the DAT KO mice.
Confounding vascular effects
Vascular effects not related to neuroactivity also have to be
considered when interpreting phMRI results. Confounding systemic
effects of cocaine have been difficult to exclude (Gozzi et al., 2007; Luo
et al., 2009). A limitation of the current study is that the arterial blood
pressure could not be monitored during scanning. However, the
transient effect (~5 min) of this cocaine dose on the systemic blood
pressure does not seem to provide a large determinant for the
sustained (~1 h) hemodynamic response in the brain (Du et al., 2009,
2006; Luo et al., 2003; Schmidt et al., 2006). Moreover, any large
peripheral blood pressure change following cocaine injection would
have resulted in a signal change in muscle tissue. Our findings suggest
that the measured CBV change in the current study is largely
independent of systemic effects of the drug.
There is evidence that the CBV responsemay depend on the type of
anesthetic used in the experiment (Du et al., 2009; Luo et al., 2009). In
previous studies, which used different anesthetics, the anesthetic
usedmay have been confounded with apparent species differences. In
a study by Du et al. (2006), a CBV decrease of −4% to −8% was
observedwith optical techniques in the cortex of rats under isoflurane
anesthesia after an intravenous dose of 1 mg/kg cocaine whether or
not a peripheral blood pressure decrease during the first minutes was
prevented by phenylephrine. Consistent anesthesia conditions were
employed throughout the present work. Comparisons among the
different genotypes are thus credible, regardless of whether the
nature of differences in CBV responses between previous studies is the
result of true species differences or procedural differences (e.g., the
choice of anesthetic). Nevertheless, care must be taken in compar-
isons with conscious animals or with results from studies that use
other anesthesia regimens.
Reward circuitry and monoamine transporter knockout mice
The cortico-mesolimbic dopaminergic circuit is thought tomediate
many of the rewarding effects of many drugs of abuse, including
cocaine, which prolongs dopaminergic transmission. However, co-
caine also elevates extracellular serotonin and norepinephrine levels
(Li et al., 1996), which may account for its pronounced rewarding
effects compared to more selective agents. Rodents, in general, and
monoamine transporter knockout mice, in particular, have been used
in efforts to identify the mechanisms of action of cocaine and other
drugs of abuse. A study by Schwarz and colleagues in rats (Schwarz et
al., 2004) has shown that the ΔCBV time course is not correlated with
the local dopamine concentration or with the local cocainearmacologic MRI: Mapping the cerebral blood volume response to
oi:10.1016/j.neuroimage.2010.12.048
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Fig. 4. Quantitative analysis of the regional CBV change after cocaine injection. Peak amplitude and the time to peak of the gamma variate fit to the signal time course are shown for
specific brain regions. The error bars indicate the standard error of the mean (N=6 per group). In all ROIs, there is a statistically significant difference (Pb0.01) between DAT KO and
wild-type mice in at least one of the three fitting parameters (the shape factor α is not shown). The overall time course of the ΔCBV response is statistically different for KO and
control mice in all ROIs except the thalamus. Typical ROI outlines are shown on two coronal brain slices: prefrontal, frontal, and frontoparietal cortex (CTX); nucleus accumbens
(ACB); caudate putamen (CP); amygdala (AMY); hippocampal formation (HPF); thalamic nuclei (TH); hypothalamus (HY); midbrain (MB); ventral tegmental area (VTA);
substantia nigra (SN); pons (P); medulla (MY); and cerebellum (CBX).
5T.-A. Perles-Barbacaru et al. / NeuroImage xxx (2010) xxx–xxxconcentration in all brain regions. A more complex mechanism for the
ΔCBV response involving other neurotransmitters and downstream
consequences of the effects produced by cocaine is supported by the
fact that, in our study, a straightforward pharmacokinetic model did
not fit the ΔCBV time course. The ΔCBV response was, therefore,
described by a gamma variate model that allowed for a gradual onset
of the ΔCBV response.
In this study, similar patterns of spatial activationwere observed in
both DAT KO andwild-type mice. The largest negative responses were
observed in the nucleus accumbens, frontal and parietal cortex, dorsal
striatum, and amygdala (in decreasing order). These structures have
substantial dopaminergic innervation and constitute a substantial
portion of the brain reward circuitry that mediates the rewarding
effects of drugs of abuse (Koob and Volkow, 2010). The time to peak
response was 12–18 min in all structures examined, except the
cerebellum where it was 20–28 min. Quantitative regional analysis
revealed a significant decrease in amplitude and a slight decrease in
duration of the hemodynamic response in DAT KO mice compared to
wild-type mice. The ΔCBV response to cocaine in these regions was
attenuated but not entirely abolished in DAT KO mice. This is
consistent with the maintenance of some reinforcing effects of
cocaine in DAT KO mice at the cocaine dose used here as indicated
by conditioned place preference (Sora et al., 2001, 1998) and cocaine
self-administration (Rocha et al., 1998) studies. However, the reduced
ΔCBV response in DAT KO mice may also be considered to be
consistent with the weaker reinforcing effects that have been
demonstrated in a more recent self-administration study (Thomsen
et al., 2009). More importantly, it may indicate a difference in the
underlying mechanism of cocaine effects in DAT KO and wild-type
mice. Cocaine continues to produce a conditioned place preference in
DAT KOmice, but DAT KOmice also exhibit novel rewarding effects of
selective SERT and NET blockers (Hall et al., 2002). The rewarding
effects of these drugs may be due to consequences of SERT and NET
blockade in the VTA/SN. Along with its rewarding effects, cocaine
continues to produce increases in extracellular dopamine in the
striatum in this strain of DAT KO mice (Shen et al., 2004). This might
be due to cocaine blockade of SERT, a hypothesis consistent with the
elimination of cocaine conditioned place preference in DAT/SERT
double KO mice (Sora et al., 2001). Furthermore, although fluoxetine,
a selective serotonin reuptake inhibitor, has no effect in wild-type
mice, it is rewarding (Hall et al, 2002) and increases striatal dopamine
levels in DAT KO mice (Shen et al., 2004). The locus of this effect mayPlease cite this article as: Perles-Barbacaru, T.-A., et al., Quantitative ph
cocaine in dopamine transporter knockout mice, NeuroImage (2010), dbe the VTA/SN, as local infusions of cocaine in either the dorsal or
ventral striatum do not increase extracellular dopamine levels in DAT
KO mice (Mateo et al., 2004; Shen et al., 2004), but local injections of
cocaine or fluoxetine into the VTA do increase extracellular dopamine
levels in the nucleus accumbens of DAT KO, but not wild-type, mice
(Mateo et al., 2004). In the present study, the greatest differences in
ΔCBV between KO and wild-type mice were observed in the VTA/SN.
These results are consistent with the hypothesis presented above that
the mechanism of cocaine-induced increases in striatal dopamine in
DAT KO mice involve at least some cocaine actions in the VTA/SN
rather than dopaminergic terminal fields.
DAT KO responses to cocaine are less negative than those of wild-
type animals in all brain regions except the pons, hypothalamus, and
medulla oblongata (and not statistically different in the thalamus).
These are all regions that are not involved in drug reward. They
display only modest densities of dopaminergic innervation. Thanos et
al. (2008) used PET measured 18F-fluorodeoxyglucose (18FDG) uptake
in DAT KO and wild-type mice to assay metabolic activity. They found
an overall decrease in baseline 18FDG uptake in DAT KO versus wild-
type mice, and increased uptake after cocaine challenge in DAT KO
mice only in the thalamus and cerebellum. In that PET study 18FDG
was introduced 30 min after cocaine injection with an 80-min
acquisition time. Thus, the 18FDG uptake reflects cocaine effects well
after the CBV changes observed here have returned to baseline. In
other studies with rats and primates using intravenous rather than IP
injection of drugs (Jenkins et al., 2004; Marota et al., 2000), both time
to maximum change in CBV and return to baseline are significantly
reduced from values observed here due to different routes of
administration. Regardless of how cocaine is administered, ΔCBV
changes measure a fast response of the reward circuit to cocaine
challenge, while 18FDG uptake evaluates longer term responses,
averaged over 80 min, that may reflect adaptations to the initial
cocaine effect. Taken together, the PET and phMRI results imply that
cocaine impacts the cortico-mesolimbic reward circuit in the first
minutes after challenge with the most impact in the more dopami-
nergically innervated anterior structures. Cocaine subsequently exerts
a more sustained influence on the more “limbic” parts of the circuit.
Conclusion
This study demonstrates the applicability of the CBV-weighted
phMRI technique to mapping hemodynamic effects of centrally actingarmacologic MRI: Mapping the cerebral blood volume response to
oi:10.1016/j.neuroimage.2010.12.048
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6 T.-A. Perles-Barbacaru et al. / NeuroImage xxx (2010) xxx–xxxdrugs in mouse models of disease. The technique is minimally
invasive and provides good functional sensitivity. We also note that,
as with other functional MRI techniques, the mechanisms underlying
the CBV changes may not be exclusively specific to neuronal
activation. The negative ΔCBV response to cocaine challenge is rapid
(~15 min) throughout the reward circuit and attenuated in DAT KO
mice. Since knockout of DAT has a small but significant effect on the
immediate response to cocaine in brain regions thought to be
involved in cocaine reward, knockout of DAT appears to produce
circuit-wide changes, not just changes in dopaminergic neurons. The
largest responses to cocaine (−20% to −30% ΔCBV) are seen in the
cortex and nucleus accumbens. There are decreasing responses in
more posterior parts of the reward circuit (CPNAMYNVTA~SN).
Nevertheless, some of the greatest differences between DAT KO and
wild-type mice were observed in midbrain structures, VTA and SN,
which may indicate a different mechanism of action of cocaine in DAT
KO mice. The fact that there are much more modest differences in the
nucleus accumbens and dorsal striatum between DAT KO and wild-
type mice is consistent with the retention of some cocaine reward,
under at least some conditions (Rocha et al., 1998; Sora et al., 2001,
1998; Thomsen et al., 2009). Thus these results emphasize the
ultimate importance of the nucleus accumbens at early as well as later
stages of drug exposure (Koob and Volkow, 2010).547
548
549
550
551
552
553
554
555
556
557
558
559
560Acknowledgments
The authors thank Hargun Sohi and Thomas Ng for their technical
assistance, Davit Janvelyan for helping with the AIR software, Guerbet
Research (Aulnay-Sous-Bois, France) for providing the P904 contrast
agent. This project was funded in part by the Beckman Institute, NIDA
R01DA18184, and NCRR U24 RR021760 Mouse BIRN and by funding
from the National Institute on Drug Abuse, Intramural Research
Program (GRU, FSH).561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602References
Abramoff, M.D., Magelhaes, P.J., Ram, S.J., 2004. Image processing with image.
J Biophotonics Int. 11, 36–42.
Berry, I., Benderbous, S., Ranjeva, J.P., Gracia-Meavilla, D., Manelfe, C., Le Bihan, D., 1996.
Contribution of Sinerem used as blood-pool contrast agent: detection of cerebral
blood volume changes during apnea in the rabbit. Magn. Reson. Med. 36, 415–419.
Ceolin, L., Schwarz, A.J., Gozzi, A., Reese, T., Bifone, A., 2007. Effects of cocaine on blood
flow and oxygen metabolism in the rat brain: implications for phMRI. Magn. Reson.
Imaging 25, 795–800.
Chen, Y.C., Mandeville, J.B., Nguyen, T.V., Talele, A., Cavagna, F., Jenkins, B.G., 2001.
Improved mapping of pharmacologically induced neuronal activation using the
IRON technique with superparamagnetic blood pool agents. J. Magn. Reson.
Imaging 14, 517–524.
Chin, C.L., Fox, G.B., Hradil, V.P., Osinski, M.A., McGaraughty, S.P., Skoubis, P.D., Cox, B.F.,
Luo, Y., 2006. Pharmacological MRI in awake rats reveals neural activity in area
postrema and nucleus tractus solitarius: relevance as a potential biomarker for
detecting drug-induced emesis. Neuroimage 33, 1152–1160.
Choi, J.K., Chen, Y.I., Hamel, E., Jenkins, B.G., 2006. Brain hemodynamic changes
mediated by dopamine receptors: role of the cerebral microvasculature in
dopamine-mediated neurovascular coupling. Neuroimage 30, 700–712.
Du, C., Tully, M., Volkow, N.D., Schiffer, W.K., Yu, M., Luo, Z., Koretsky, A.P., Benveniste,
H., 2009. Differential effects of anesthetics on cocaine's pharmacokinetic and
pharmacodynamic effects in brain. Eur. J. Neurosci. 30, 1565–1575.
Du, C., Yu, M., Volkow, N.D., Koretsky, A.P., Fowler, J.S., Benveniste, H., 2006. Cocaine
increases the intracellular calcium concentration in brain independently of its
cerebrovascular effects. J. Neurosci. 26, 11522–11531.
El-Ghundi, M., O'Dowd, B.F., George, S.R., 2007. Insights into the role of dopamine
receptor systems in learning and memory. Rev. Neurosci. 18, 37–66.
Gainetdinov, R.R., Caron, M.G., 2003. Monoamine transporters: from genes to behavior.
Annu. Rev. Pharmacol. Toxicol. 43, 261–284.
Girault, J.A., Greengard, P., 2004. The neurobiology of dopamine signaling. Arch. Neurol.
61, 641–644.
Gozzi, A., Ceolin, L., Schwarz, A., Reese, T., Bertani, S., Crestan, V., Bifone, A., 2007. A
multimodality investigation of cerebral hemodynamics and autoregulation in
pharmacological MRI. Magn. Reson. Imaging 25, 826–833.
Hall, F.S., Li, X.F., Randall-Thompson, J., Sora, I., Murphy, D.L., Lesch, K.P., Caron, M., Uhl,
G.R., 2009. Cocaine-conditioned locomotion in dopamine transporter, norepineph-
rine transporter and 5-HT transporter knockout mice. Neuroscience 162, 870–880.Please cite this article as: Perles-Barbacaru, T.-A., et al., Quantitative ph
cocaine in dopamine transporter knockout mice, NeuroImage (2010), dHall, F.S., Li, X.F., Sora, I., Xu, F., Caron, M., Lesch, K.P., Murphy, D.L., Uhl, G.R., 2002.
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place prefer-
ences following monoamine transporter deletions. Neuroscience 115, 153–161.
Jamshidi, H.R., Rezayat, M., Zarrindast, M.R., 2004. Effect of apmin on tolerance to
cocaine-induced locomotor activity in mice. Acta Med. Iran. 42, 78–82.
Jenkins, B.G., Sanchez-Pernaute, R., Brownell, A.-L., Chen, Y.-C.I., Isacson, O., 2004.
Mapping dopamine function in primates using pharmacologic magnetic resonance
imaging. J. Neurosci. 24, 9553–9560.
Johanson, C.E., Fischman, M.W., 1989. The pharmacology of cocaine related to its abuse.
Pharmacol. Rev. 41, 3–52.
Kaufman, M.J., Levin, J.M., Maas, L.C., Rose, S.L., Lukas, S.E., Mendelson, J.H., Cohen, B.M.,
Renshaw, P.F., 1998. Cocaine decreases relative cerebral blood volume in humans: a
dynamic susceptibility contrast magnetic resonance imaging study. Psychophar-
macology 138, 76–81.
Koob, G.F., Volkow, N.D., 2010. Neurocircuitry of addiction. Neuropsychopharmacology
35, 217–238.
Krimer, L.S., Muly III, E.C., Williams, G.V., Goldman-Rakic, P.S., 1998. Dopaminergic
regulation of cerebral cortical microcirculation. Nat. Neurosci. 1, 286–289.
Leslie, R.A., James, M.F., 2000. Pharmacological magnetic resonance imaging: a new
application for functional MRI. Trends Pharmacol. Sci. 21, 314–318.
Li, M.Y., Yan, Q.S., Coffey, L.L., Reith, M.E.A., 1996. Extracellular dopamine, norepinephrine,
and serotonin in the nucleus accumbens of freely moving rats during intracerebral
dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66,
559–568.
Luo, F., Seifert, T.R., Edalji, R., Loebbert, R.W., Hradil, V.P., Harlan, J., Schmidt, M.,
Nimmrich, V., Cox, B.F., Fox, G.B., 2008. Non-invasive characterization of beta-
amyloid(1–40) vasoactivity by functional magnetic resonance imaging in mice.
Neuroscience 155, 263–269.
Luo, F., Wu, G., Li, Z., Li, S.J., 2003. Characterization of effects of mean arterial blood
pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain.
Magn. Reson. Med. 49, 264–270.
Luo, Z., Yuan, Z., Tully, M., Pan, Y., Du, C., 2009. Quantification of cocaine-induced
cortical blood flow changes using laser speckle contrast imaging and Doppler
optical coherence tomography. Appl. Opt. 48, D247–255.
Lyons, D., Friedman, D.P., Nader, M.A., Porrino, L.J., 1996. Cocaine alters cerebral
metabolism within the ventral striatum and limbic cortex of monkeys. J. Neurosci.
16, 1230–1238.
Mandeville, J.B., Ekstrom, L., Marota, J.J.A., Jenkins, B.G., Vanduffel, W., 2005. Contrast-
enhanced fMRI of cocaine action in awake, non-human primate. Proceedings of the
International Society for Magnetic Resonance in Medicine.
Mandeville, J.B., Jenkins, B.G., Chen, Y.C., Choi, J.K., Kim, Y.R., Belen, D., Liu, C., Kosofsky,
B.E., Marota, J.J., 2004. Exogenous contrast agent improves sensitivity of gradient-
echo functional magnetic resonance imaging at 9.4T. Magn. Reson. Med. 52,
1272–1281.
Mandeville, J.B., Marota, J.J., Kosofsky, B.E., Keltner, J.R., Weissleder, R., Rosen, B.R.,
Weisskoff, R.M., 1998. Dynamic functional imaging of relative cerebral blood
volume during rat forepaw stimulation. Magn. Reson. Med. 39, 615–624.
Marota, J.J., Mandeville, J.B., Weisskoff, R.M., Moskowitz, M.A., Rosen, B.R., Kosofsky,
B.E., 2000. Cocaine activation discriminates dopaminergic projections by temporal
response: an fMRI study in Rat. Neuroimage 11, 13–23.
Mateo, Y., Budygin, E.A., John, C.E., Jones, S.R., 2004. Role of serotonin in cocaine effects
in mice with reduced dopamine transporter function. Proc. Natl Acad. Sci. USA 101,
372–377.
Mueggler, T., Baumann, D., Rausch, M., Staufenbiel, M., Rudin, M., 2003. Age-dependent
impairment of somatosensory response in the amyloid precursor protein 23
transgenic mouse model of Alzheimer's disease. J. Neurosci. 23, 8231–8236.
Peoples, L.L., Gee, F., Bibi, R., West, M.O., 1998. Phasic firing time locked to cocaine self-
infusion and locomotion: dissociable firing patterns of single nucleus accumbens
neurons in the rat. J. Neurosci. 18, 7588–7598.
Perles-Barbacaru, A.T., Procissi, D., Demyanenko, A.V., Jacobs, R.E., 2010. Nonlinear
model for preprocessing of cerebral blood volume weighted functional MRI data
and for evaluating pharmacokinetic properties of USPIO. Proc. Intl. Soc. Mag. Reson.
Med. 18th Annual Scientific Meeting, Stockholm (Sweden), p. 3550.
Rocha, B.A., Fumagalli, F., Gainetdinov, R.R., Jones, S.R., Ator, R., Giros, B., Miller, G.W.,
Caron, M.G., 1998. Cocaine self-administration in dopamine-transporter knockout
mice. Nat. Neurosci. 1, 132–137.
Sanchez-Pernaute, R., Jenkins, B.G., Choi, J.K., Iris Chen, Y.C., Isacson, O., 2007. In vivo
evidence of D3 dopamine receptor sensitization in parkinsonian primates and
rodents with L-DOPA-induced dyskinesias. Neurobiol. Dis. 27, 220–227.
Schmidt, K.F., Febo, M., Shen, Q., Luo, F., Sicard, K.M., Ferris, C.F., Stein, E.A., Duong, T.Q.,
2006. Hemodynamic and metabolic changes induced by cocaine in anesthetized
rat observed with multimodal functional MRI. Psychopharmacol. Berl 185,
479–486.
Schwarz, A.J., Gozzi, A., Reese, T., Bifone, A., 2007a. In vivo mapping of functional
connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage
34, 1627–1636.
Schwarz, A.J., Gozzi, A., Reese, T., Heidbreder, C.A., Bifone, A., 2007b. Pharmacological
modulation of functional connectivity: the correlation structure underlying the
phMRI response to d-amphetamine modified by selective dopamine D3 receptor
antagonist SB277011A. Magn. Reson. Imaging 25, 811–820.
Schwarz, A.J., Reese, T., Gozzi, A., Bifone, A., 2003. Functional MRI using intravascular
contrast agents: detrending of the relative cerebrovascular (rCBV) time course.
Magn. Reson. Imaging 21, 1191–1200.
Schwarz, A.J., Zocchi, A., Reese, T., Gozzi, A., Garzotti, M., Varnier, G., Curcuruto, O.,
Sartori, I., Girlanda, E., Biscaro, B., Crestan, V., Bertani, S., Heidbreder, C., Bifone, A.,
2004. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal aarmacologic MRI: Mapping the cerebral blood volume response to
oi:10.1016/j.neuroimage.2010.12.048
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
7T.-A. Perles-Barbacaru et al. / NeuroImage xxx (2010) xxx–xxxcomplex relationship between the central hemodynamic response and local
dopamine concentration. Neuroimage 23, 296–304.
Shen, H.W., Hagino, Y., Kobayashi, H., Shinohara-Tanaka, K., Ikeda, K., Yamamoto, H.,
Yamamoto, T., Lesch, K.P., Murphy, D.L., Hall, F.S., Uhl, G.R., Sora, I., 2004. Regional
differences in extracellular dopamine and serotonin assessed by in vivo micro-
dialysis in mice lacking dopamine and/or serotonin transporters. Neuropsycho-
pharmacology 29, 1790–1799.
Sigovan, M., Boussel, L., Sulaiman, A., Sappey-Marinier, D., Alsaid, H., Desbleds-Mansard,
C., Ibarrola, D., Gamondes, D., Corot, C., Lancelot, E., Raynaud, J.S., Vives, V.,
Lacledere, C., Violas, X., Douek, P.C., Canet-Soulas, E., 2009. Rapid-clearance iron
nanoparticles for inflammation imaging of atherosclerotic plaque: initial experi-
ence in animal model. Radiology 252, 401–409.
Sora, I., Hall, F.S., Andrews, A.M., Itokawa, M., Li, X.F., Wei, H.B., Wichems, C., Lesch, K.P.,
Murphy, D.L., Uhl, G.R., 2001. Molecular mechanisms of cocaine reward: combined
dopamine and serotonin transporter knockouts eliminate cocaine place preference.
Proc. Natl Acad. Sci. USA 98, 5300–5305.
Sora, I., Wichems, C., Takahashi, N., Li, X.F., Zeng, Z., Revay, R., Lesch, K.P., Murphy, D.L.,
Uhl, G.R., 1998. Cocaine reward models: conditioned place preference can be
established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl
Acad. Sci. USA 95, 7699–7704.Please cite this article as: Perles-Barbacaru, T.-A., et al., Quantitative ph
cocaine in dopamine transporter knockout mice, NeuroImage (2010), dThanos, P.K., Michaelides, M., Benveniste, H., Wang, G.J., Volkow, N.D., 2008. The effects
of cocaine on regional brain glucose metabolism is attenuated in dopamine
transporter knockout mice. Synapse 62, 319–324.
Thomas, M.J., Kalivas, P.W., Shaham, Y., 2008. Neuroplasticity in the mesolimbic
dopamine system and cocaine addiction. Br. J. Pharmacol. 154, 327–342.
Thomsen, M., Hall, F.S., Uhl, G.R., Caine, S.B., 2009. Dramatically decreased cocaine self-
administration in dopamine but not serotonin transporter knock-out mice.
J. Neurosci. 29, 1087–1092.
Uhl, G.R., Hall, F.S., Sora, I., 2002. Cocaine, reward, movement and monoamine
transporters. Mol. Psychiatry 7, 21–26.
Weissleder, R., Elizondo, G., Wittenberg, J., Rabito, C.A., Bengele, H.H., Josephson, L.,
1990. Ultrasmall superparamagnetic iron oxide: characterization of a new class of
contrast agents for MR imaging. Radiology 175, 489–493.
Woods, R.P., Grafton, S.T., Holmes, C.J., Cherry, S.R., Mazziotta, J.C., 1998. Automated
image registration: I. General methods and intrasubject, intramodality validation.
J. Comput. Assist. Tomogr. 22, 139–152.
Wu, E.X., Tang, H., Asai, T., Yan, S.D., 2004. Regional cerebral blood volume reduction in
transgenic mutant APP (V717F, K670N/M671L) mice. Neurosci. Lett. 365, 223–227.
Zocchi, A., Conti, G., Orzi, F., 2001. Differential effects of cocaine on local cerebral glucose
utilization in the mouse and in the rat. Neurosci. Lett. 306, 177–180.armacologic MRI: Mapping the cerebral blood volume response to
oi:10.1016/j.neuroimage.2010.12.048
